Application of the CARE Guideline as reporting standard in Annals of Infection

Annals of Infection welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.

For completeness and transparency for published case reports, Annals of Infection will apply the CARE guidelines (1) as reporting standards for case reports starting from October 14, 2019. For any submission of case report after the date:

Read More>>

Inauguration of Annals of Infection

We hope that Annals of Infection would be a favorable choice for both authors and readers in the field of infection. We are sure that this could be definitely achieved with the support from our top class scientists in our Editorial Board. We welcome the community to join us on this journey to make this project a successful one!

Read More>>

Cefazolin or nafcillin? —a commentary on the optimal treatment of methicillin-susceptible Staphylococcus aureus bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins

Over 90% of Staphylococcus aureus strains produce a Bla, which hydrolyze penicillin (16). There have been four different types identified, A, B, C, and D (16). Type A Blas have demonstrated the most enhanced hydrolysis of cefazolin over ASPs with type C also maintaining some activity (16). Despite the limitations from the inoculum effect, cefazolin has many advantageous qualities compared to ASPs, as shown in Table 1.

Read More>>

Chronic prostatitis and small intestinal bacterial overgrowth: is there a correlation?

A positive lactulose BT was present in 33/42 patients and in 73% (24/33) was associated to lactose malabsorption. Five patients had positive response after lactulose, while only 4 had both negative tests.

Read More>>